STANDARD BIOTOOLS INC (LAB) Stock Earnings & Estimates
NASDAQ:LAB - US34385P1084 - Common Stock
1.29 USD
+0.05 (+4.03%)
1.29 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 97.9M -25.04% | 106.34M 8.62% | 174.432M 64.03% | 169.7M -2.71% | 116.5M -31.35% | 148.2M 27.21% | 88.274M -40.44% | |
| EBITDA YoY % growth | -101.17M -94.82% | -47.859M 52.69% | -117.896M -146.34% | -60.566M 48.63% | -22.287M 63.20% | 52.217M 334.29% | 3.838M -92.65% | |
| EBIT YoY % growth | -116.2M -72.15% | -63.039M 45.75% | -134.757M -113.77% | -98.324M 27.04% | -87.416M 11.09% | -66.458M 23.97% | -55.348M 16.72% | |
| Operating Margin | -118.69% | -59.28% | -77.25% | -57.94% | -75.03% | -44.84% | -62.70% | |
| EPS YoY % growth | N/A | -0.85 | -0.55 35.29% | -0.31 43.07% | -0.24 22.58% | -0.18 25.00% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 20.64% | -0.06 38.28% | -0.05 27.86% | -0.05 43.89% | -0.05 9.09% | -0.05 9.09% |
| Revenue Q2Q % growth | 18.178M -59.58% | 19.502M -58.26% | 19.527M -52.13% | 20.84M -50.34% | 34.293M 88.65% | 35.865M 83.90% |
| EBITDA Q2Q % growth | -11.211M 1.57% | -11.952M 7.17% | -10.757M 58.82% | -11.009M 29.13% | -9.191M 18.02% | -1.364M 88.59% |
| EBIT Q2Q % growth | -22.321M 8.14% | -23.129M 22.22% | -19.695M 34.99% | -19.998M 15.62% | -19.594M 12.22% | -18.584M 19.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.09 25.00% | -0.08 | -0.01 | -11.39% |
| Q1 2025 Q2Q % growth | -0.07 74.07% | -0.08 | 0.01 | 7.59% |
| Q4 2024 Q2Q % growth | -0.09 64.00% | -0.07 | -0.02 | -27.30% |
| Q3 2024 Q2Q % growth | -0.07 74.07% | -0.09 | 0.02 | 22.99% |
| Q2 2024 Q2Q % growth | -0.12 45.45% | -0.09 | -0.03 | -39.78% |
| Q1 2024 Q2Q % growth | -0.27 -145.45% | -0.11 | -0.16 | -135.88% |
| Q4 2023 Q2Q % growth | -0.25 -31.58% | -0.13 | -0.12 | -90.40% |
| Q3 2023 Q2Q % growth | -0.27 -3.85% | -0.12 | -0.15 | -122.77% |
| Q2 2023 Q2Q % growth | -0.22 33.33% | -0.21 | -0.01 | -3.72% |
| Q1 2023 Q2Q % growth | -0.11 56.00% | % | ||
| Q4 2022 Q2Q % growth | -0.19 -58.33% | % | ||
| Q3 2022 Q2Q % growth | -0.26 -44.44% | % | ||
| Q2 2022 Q2Q % growth | -0.33 -43.48% | % | ||
| Q1 2022 Q2Q % growth | -0.25 | % | ||
| Q4 2021 Q2Q % growth | -0.12 50.00% | -0.28 | 0.16 | 57.57% |
| Q3 2021 Q2Q % growth | -0.18 -125.00% | -0.22 | 0.04 | 18.99% |
| Q2 2021 Q2Q % growth | -0.23 -27.78% | -0.20 | -0.03 | -16.78% |
| Q1 2021 Q2Q % growth | -0.25 -8.70% | -0.14 | -0.11 | -72.70% |
| Q4 2020 Q2Q % growth | -0.24 -33.33% | -0.07 | -0.17 | -256.42% |
| Q3 2020 Q2Q % growth | -0.08 57.89% | -0.20 | 0.12 | 60.40% |
| Q2 2020 Q2Q % growth | -0.18 10.00% | -0.23 | 0.05 | 22.51% |
| Q1 2020 Q2Q % growth | -0.23 17.86% | -0.15 | -0.08 | -51.82% |
| Q4 2019 Q2Q % growth | -0.18 | -0.19 | 0.01 | 5.20% |
| Q3 2019 Q2Q % growth | -0.19 | -0.20 | 0.01 | 6.87% |
| Q2 2019 Q2Q % growth | -0.20 | -0.21 | 0.01 | 4.80% |
| Q1 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -10.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 41.962M 12.79% | 40.222M | 1.74M | 4.33% |
| Q1 2025 Q2Q % growth | 40.795M -10.42% | 40.501M | 294K | 0.73% |
| Q4 2024 Q2Q % growth | 46.718M 65.74% | 43.464M | 3.254M | 7.49% |
| Q3 2024 Q2Q % growth | 44.969M 77.27% | 41.408M | 3.561M | 8.60% |
| Q2 2024 Q2Q % growth | 37.205M 35.36% | 48.733M | -11.528M | -23.66% |
| Q1 2024 Q2Q % growth | 45.54M 81.29% | 46.466M | -926K | -1.99% |
| Q4 2023 Q2Q % growth | 28.188M 4.32% | 25.149M | 3.039M | 12.08% |
| Q3 2023 Q2Q % growth | 25.367M -1.10% | 23.836M | 1.531M | 6.42% |
| Q2 2023 Q2Q % growth | 27.486M 46.36% | 24.442M | 3.044M | 12.45% |
| Q1 2023 Q2Q % growth | 25.12M -5.21% | % | ||
| Q4 2022 Q2Q % growth | 27.02M -29.40% | % | ||
| Q3 2022 Q2Q % growth | 25.65M -10.00% | % | ||
| Q2 2022 Q2Q % growth | 18.78M -39.46% | % | ||
| Q1 2022 Q2Q % growth | 26.5M -19.18% | % | ||
| Q4 2021 Q2Q % growth | 38.27M -14.21% | 33.027M | 5.243M | 15.87% |
| Q3 2021 Q2Q % growth | 28.5M -28.50% | 30.3M | -1.8M | -5.94% |
| Q2 2021 Q2Q % growth | 31.02M 19.03% | 31.326M | -306K | -0.98% |
| Q1 2021 Q2Q % growth | 32.79M 18.72% | 32.291M | 499K | 1.55% |
| Q4 2020 Q2Q % growth | 44.61M 37.52% | 51.227M | -6.617M | -12.92% |
| Q3 2020 Q2Q % growth | 39.86M 50.42% | 32.783M | 7.077M | 21.59% |
| Q2 2020 Q2Q % growth | 26.06M -7.59% | 19.261M | 6.799M | 35.30% |
| Q1 2020 Q2Q % growth | 27.62M -8.27% | 29.32M | -1.7M | -5.80% |
| Q4 2019 Q2Q % growth | 32.44M | 31.148M | 1.292M | 4.15% |
| Q3 2019 Q2Q % growth | 26.5M | 29.023M | -2.523M | -8.69% |
| Q2 2019 Q2Q % growth | 28.2M | 30.363M | -2.163M | -7.12% |
| Q1 2019 Q2Q % growth | 30.11M | 29.488M | 622K | 2.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 26.67% | -83.33% | -12.73% | -10.71% |
| Revenue | -55.97% | -61.54% | -0.67% | -0.67% |